RAYLYTIC logo — AI-powered software for MedTechs, CROs, Pharma, Clinicians,...

RAYLYTIC

AI-powered software for MedTechs, CROs, Pharma, Clinicians, Researchers & Registries

Founded 2017 Germany Leipzig, Germany 15 employees Convertible Note Total: $9.46M AI, Big Data +4

General Information

Company Name RAYLYTIC
Founded Year 2017
Location Germany Leipzig, Germany
Employees 15
Industries AI, Big Data, Digital Health +3
Funding Stage Convertible Note
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Project Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with RAYLYTIC. To contact RAYLYTIC, visit raylytic.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RAYLYTIC compare?

A PDF of RAYLYTIC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RAYLYTIC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Sep 24, 2026

RAYLYTIC secured a deal with Axis Spine Technologies, providing imaging core lab services for their latest study on a modular anterior lumbar interbody fusion (ALIF) cage.

About RAYLYTIC

RAYLYTIC, established in 2017, is a Germany-based innovator specializing in AI-powered solutions tailored for MedTechs, CROs, Pharma, clinicians, researchers, and registries. The company leverages Big Data and digitalization to transform healthcare through the efficient management of regulatory requirements for clinical studies and trials.

Operating within an emerging synergy of Digital Health, Health Care, Medical Devices, and Pharmaceutical industries, RAYLYTIC is at the forefront of utilizing data to automate healthcare processes, enhancing patient-centered care through advanced medical data management.

The company's latest financial milestone is a €1.80 million convertible note investment secured on 01 March 2023. This capital injection underscores investor confidence in RAYLYTIC's innovation trajectory and potential market impact in the rapidly evolving digital health landscape.

Business keywords: AI-powered software, MedTech, CROs, Pharmaceuticals, Clinical trials, Medical data management, Automation in healthcare, Medical image analysis, Clinical data extraction, Digitalization in healthcare, Patient-centered care, Regulatory requirements management, Evidence-based medicine, Machine learning in medicine, Patient reported outcome measures (PROMs)

Services & Products

KI-gestützte Bildanalyse & -management
EDC-System
Imaging Core Lab
Automatisierte Datenerfassung
PROMs & PREMs Integration

Target Customers

Krankenhäuser Kliniken Ärzte Sponsoren klinischer Studien CROs (Contract Research Organizations) Forschungsnetzwerke Gesundheitseinrichtungen

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note €1.80M -
01 Mar 2023
Convertible Note €3.50M -
26 May 2022
Grant €1.97M 1
Federal Ministry for Economic Affairs and Energy (BMWi)
13 Dec 2019
Convertible Note €525.00K 2
TGFS - Technologiegründerfonds Sachsen, Frank Trautwein
31 Aug 2019
Grant €229.58K -
04 Apr 2019
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Jan 2019
Debt Financing €100.00K -
15 Dec 2017
Seed Round €1.29M 2
TGFS - Technologiegründerfonds Sachsen, Frank Trautwein
18 Jun 2017

RAYLYTIC Alternatives & Competitors

View All Alternatives
RAYLYTIC vs

We enable patients, clinicians and researchers to improve care pathways and quality of life.

Series A
38 employees
Digital Health, Health Care
RAYLYTIC vs

Radiomics, Deep Learning & Federated Learning for AI powered drug development trajectory and persona...

24 employees
AI, Biotechnology
RAYLYTIC vs

Follow us to stay updated on our findings on value-based health care derived from our growing set of...

Merged
26 employees
Biotechnology, Digital Health

FAQ About RAYLYTIC

AI-powered software for MedTechs, CROs, Pharma, Clinicians, Researchers & Registries
RAYLYTIC was founded in 2017.
RAYLYTIC is headquartered in Leipzig, Germany.
RAYLYTIC operates in AI, Big Data, Digital Health, Health Care, Medical Devices and Pharmaceutical. Its work centres on AI-powered software, MedTech, CROs and Pharmaceuticals. Its customers include Krankenhäuser, Kliniken and Ärzte.
RAYLYTIC has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Project Based and Service Fee.
RAYLYTIC has approximately 15 employees.
RAYLYTIC has completed 8 funding rounds, raising a total of $9.46M. The latest funding stage is Convertible Note.
RAYLYTIC offers: KI-gestützte Bildanalyse & -management, EDC-System, Imaging Core Lab, Automatisierte Datenerfassung, PROMs & PREMs Integration.
Top alternatives and competitors to RAYLYTIC include Heartbeat Medical, radiomics.bio, moveUP - digital therapies, Hyfe, OutcomeMD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RAYLYTIC and Heartbeat Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RAYLYTIC, https://bouncewatch.com/company/raylytic, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes